Lipid Profile Measurements Research Articles

State of type 2 diabetic Iraqi patients after hospitalization for COVID-19

Background The coronavirus-19 (COVID-19) pandemic, triggered by the severe acute respiratory syndrome coronavirus 2, has affected over 100 million people and killed around 2 million individuals. One of the most common chronic illnesses in the world is diabetes, which greatly raises the risk of hospitalization and death for COVID-19 patients. Objective This study aims to analyze the novel coronavirus's general characteristics and shed light on COVID-19 and its management in diabetic individuals by measuring some metabolic and inflammatory factors in type 2 diabetic patients with and without COVID-19. Methods One hundred Iraqi patients with type 2 diabetes mellitus (T2DM) were enrolled in the current study; 50 had COVID-19 with the Omicron variant, and 50 weren't. The diagnosis was designed by the consultant medical staff at the clinic. Eligible individuals had a positive nasal swab for reverse transcription polymerase chain reaction for severe acute respiratory syndrome coronavirus 2 infection. They were compared with 50 healthy individuals as a control group. Every participant's anthropometric and clinical features were measured. The study includes the study groups’ glycemic, lipid profile, serum urea, and C-reactive protein (CRP) measurements. Results There were remarkable rises ( p < 0.05) in fasting and random blood glucose, serum lipid, and urea levels in diabetic patients with COVID-19 compared to those without COVID-19 and the control group. Also, a significant elevation ( p = 0.01) was found in fasting serum insulin among diabetic patients with COVID-19 as compared to those without COVID-19 and the control group (32.75 ± 8.63 vs. 25.82 ± 3.50 and 10.65 ± 1.12) µU/L, respectively. Serum CRP levels significantly increased ( p = 0.0001) in diabetic patients with COVID-19 compared to other groups. Conclusion Hyperglycemia, hyperinsulinemia, and dyslipidemia resulting from cytokine storm significantly increased the risk of hospitalization and death among coronavirus disease-19 patients. It has been concluded that T2DM reliably predicts morbidity among COVID-19 patients presenting with symptoms suggestive of severe hyperglycemia. The results also show the temporary and reversible deficiency in insulin secretion associated with severe acute respiratory syndrome coronavirus-2 infection. Consequently, it is recommended to examine variables of insulin sensitivity and pancreatic islet activity among patients with COVID-19 who have a history of diabetes.

NLRP3 Inhibitor Alleviates Glycemic Variability-Induced Cognitive Impairment in Aged Rats with Type 2 Diabetes Mellitus

Glycemic variability (GV) markedly exacerbates cognitive impairment in elderly patients with type 2 diabetes mellitus (T2DM), in part through chronic inflammation. This study investigated the therapeutic efficacy of the NLRP3 inflammasome inhibitor MCC950 in mitigating GV-induced cognitive impairment in an aged rat model of T2DM. Aged Sprague-Dawley rats with induced T2DM were subjected to GV conditions, and the effects of MCC950 were evaluated through measurement of body weight, blood glucose, lipid profiles, insulin level, inflammatory markers, and cognitive function. Transcriptomic analysis was performed on the hippocampus and prefrontal cortex. Treatment with MCC950 significantly alleviated weight loss and hyperglycemia in the GV group compared with the control group. MCC950 also reduced the levels of cholesterol, triglycerides, and pro-inflammatory markers (interleukin-1β (IL-1β) and interleukin-18 (IL-18)). Most notably, MCC950 improved spatial learning and memory retention in the GV group. Immunohistochemical analysis indicated a reduction in inflammasome activation and an increase in the expression level of the neuronal marker NeuN in the hippocampus. Transcriptomic analysis revealed that MCC950 altered neuroactive ligand-receptor interaction pathways in the hippocampus and influenced receptor binding and cell adhesion processes in the prefrontal cortex. These findings validated the efficacy of NLRP3 inhibitor in mitigating GV-induced cognitive impairment in elderly rats with T2DM and provided the basis for subsequent clinical studies exploring the broader potential of NLRP3-targeted interventions in addressing diabetes-associated cognitive impairment.

In silico investigation and in vivo effect of Berastagi orange (Citrus sinensis) peel extract on male obese rats

Our previous studies show that Berastagi orange peel extract (BOPE) has anti-obesity properties, indicated by its active compounds and effects on reducing body weight gain and body fat percentage. This present study further analysed the effects of BOPE by evaluating docking analysis of BOPE’s phytochemicals and measuring lipid profiles, atherogenic indexes, triglyceride metabolism-related proteins (CD36, DGAT1, and DGAT2) levels, and dipeptidyl peptidase-4 (DPP4) activity in high-fat high-fructose (HFHFr)-induced obese rats. Docking analysis shows that BOPE’s phytochemicals, i.e., naringenin and hesperidin, potentially inhibit CD36 and DGAT1. BOPE significantly reduced LDL cholesterol, triglyceride levels, and DPP4 activity while increasing HDL cholesterol levels. BOPE also improved atherogenic indexes, indicating that BOPE has anti-atherosclerotic and cardioprotective effects. However, no significant effect was observed in the levels of triglyceride metabolism-related proteins, thus warranting further research towards the development of BOPE as a nutraceutical product for obesity prevention and treatment.

Using a Cross-Sectional Analysis of Age-Related Variations in Anthropometric Indices and their Association with Cardiometabolic Health in Adult Men

Background. Age-related changes in anthropometric indices and their association with cardiometabolic health markers are crucial for understanding health risks in adult men. Objectives. The study aimed to assess age-related variations in anthropometric indices and their correlation with health markers, highlighting potential cardiometabolic health risks in adult men. Materials and methods. A total of 200 men, aged 26 to 50 years, from Delhi-National Capital Region (NCR), India, were sampled using a multistage random sampling technique and divided into 5 age groups, each including 40 individuals. This study examined variations in body measurements such as the hip circumference (HC), waist circumference (WC), body mass index (BMI), and neck circumference (NC) across different age groups, as well as their relationship to health markers like HbA1c and lipid profile. Anthropometric measurements were taken in a standardized environment, and blood samples were taken under fasting conditions for lipid profile and HbA1c measurement. With SPSS software, descriptive statistics, a one-way ANOVA, and the Pearson correlation coefficients were used to analyze the data. Results. Significant age-related differences were found in NC and WC, with NC increasing from 39.61 ± 2.53 cm to 41.20 ± 2.63 cm and WC rising from 89.68 ± 12.08 cm to 98.80 ± 9.90 cm, indicating a trend toward central obesity. BMI and HC showed no considerable variation across age groups. A one-way ANOVA revealed significant differences in NC (F = 3.586, p = 0.008) and WC (F = 6.020, p = 0.005). Pearson’s correlations indicated that NC, BMI, and WC were positively correlated with triglycerides, LDL, and VLDL levels (p < 0.05), while no notable correlations were observed for HbA1c. Conclusions. The study underscores the existence of significant age-related increases in NC and WC, suggesting heightened risks of abdominal obesity and cardiometabolic health issues in older men. Monitoring these anthropometric indices is vital for the early detection of health risks in adult males.

Windows of Susceptibility to Air Pollution During and Surrounding Pregnancy in Relation to Longitudinal Maternal Measures of Adiposity and Lipid Profiles.

Pregnancy is a critical window for long-term metabolic programming of fetal effects stemming from airborne particulate matter ≤2.5μm (PM 2.5 ) exposure. Yet, little is known about long-term metabolic effects of PM 2.5 exposure during and surrounding pregnancy in mothers. We assessed potential critical windows of PM 2.5 exposure during and surrounding pregnancy with maternal adiposity and lipid measures later in life. We included 517 pregnant women from the PROGRESS cohort with adiposity [body mass index (BMI), waist circumference (WC), % body fat] and lipids [total cholesterol, high-density-lipoprotein (HDL), low-density-lipoprotein (LDL)] measured repeatedly at 4, 6 and 8 years post-delivery. Monthly average PM 2.5 exposure was estimated at each participant's address using a validated spatiotemporal model. We employed distributed lag interaction models (DLIMs) adjusting for socio-demographics and clinical covariates. We found that a 1 μg/m 3 increase in PM 2.5 exposure throughout mid-/late-pregnancy was associated with higher WC at 6-years post-delivery, peaking at 6 months of gestation: 0.04 cm (95%CI: 0.01, 0.06). We also identified critical windows of PM 2.5 exposure during and surrounding pregnancy associated with higher LDL and lower HDL both measured at 4 years post-delivery with peaks at pre-conception for LDL [0.17 mg/dL (95%CI: 0.00, 0.34)] and at the 11 th month after conception for HDL [-0.07 mg/dL (95%CI: -0.11, -0.02)]. Stratified analyses by fetal sex indicated stronger associations with adiposity measures in mothers carrying a male, whereas stronger associations were observed with lipids in mothers carrying a female fetus. Stratified analyses also indicated potential stronger deleterious lagged effects in women with folic acid intake lower than 600mcg/day during pregnancy.

Pulse wave analysis as a tool to assess endothelial function following lipid lowering intervention in hypercholesterolemia

BackgroundPulse wave analysis (PWA) assesses endothelial dependent vasodilation (EDV) via the change in augmentation index (AIx) and has been used as a tool to assess endothelial function. However, its effectiveness in assessing the response to lipid lowering treatment has not been evaluated. The study aimed to describe and correlate the change in EDV following lipid lowering intervention in patients with hypercholesterolemia. Methods48 newly diagnosed patients with hypercholesterolemia underwent 6 months intervention with statin and/or therapeutic lifestyle changes (TLC) in clinical setting. Lipid profile measurement and endothelial function assessment using PWA were performed pre- and post-intervention. ResultsSignificant reductions in low density lipoprotein cholesterol (LDL-C), non-high density lipoprotein cholesterol (non-HDL-C) and total cholesterol (TC) with corresponding significant improvement in EDV (2.94 ± 3.69 % to 7.50 ± 3.79 %, p < 0.001) were observed following intervention. Sub-analyses revealed greater LDL-C reductions and EDV improvements in the statin group compared to TLC. There was a significant inverse correlation between the change in EDV and the change in LDL-C after intervention (r = −0.298, p = 0.040). ConclusionEndothelial function assessed by PWA showed a parallel change with lipid profile pattern following lipid lowering intervention. The simple and non-invasive method may provide a potential tool for evaluating endothelial function and treatment outcomes in patients with hypercholesterolemia.

Interplay between lipid profile and anthropometric measures as indicators of cardiometabolic risk in women with polycystic ovary syndrome.

Polycystic ovary syndrome (PCOS) is a complex endocrine disorder that often coexists with cardiometabolic risk factors. Women with PCOS have a two-fold increased risk of developing type 2 diabetes and substantially elevated risk for cardiovascular disease (CVD) events later in life. PCOS patients may require more comprehensive metabolic screening to identify populations at higher risk of developing CVD and dyslipidemia. It is recommended to evaluate lipid profile, glucose tolerance and of women with PCOS every 2-3 years. Simple, short, and easy methods for the assessment of CVD risk in women with PCOS may be useful tools for implementing CVD prevention strategies by doctors or nutritionists. The aim of this study was to investigate the usefulness of anthropometric indices in the assessment of cardiometabolic risk based on lipid profile in patients with PCOS. The study involved 49 of Caucasian women aged 18-39 who were diagnosed with PCOS based on the Rotterdam criteria and divided into two groups with normal lipid profile (N=14) and dyslipidemia (N=35). Biochemical parameters were tested in the morning while fasting. Anthropometric parameters such as Body Mass Index (BMI), Body Adiposity Index (BAI), Waist-to-Hip Ratio (WHR), and Waist-to-Height Ratio (WHtR) were calculated, while the Percent of Body Fat was measured using a body analyzer. The study demonstrated that women with dyslipidemia were older than the control group, 33 years (27-37) vs 24 years (21-26), p<0.01. Neither BMI nor BAI (%) correlated with total cholesterol (p=0.63 and p=0.27). Other lipid parameters, such as serum HDL cholesterol (R=-0.68, p<0.01; R=-0.58, p<0.01), LDL cholesterol (R=0.34, p=0.02; R=0.37, p=0.01), non-HDL cholesterol (R=0.40, p<0.01; R=0.42, p<0.01), and triglycerides (R=0.56, p<0.01; R=0.51, p<0.01) correlated with BMI and BAI (%). ROC analysis demonstrated a high predictive value for age in identifying dyslipidemia. ROC analysis demonstrated poor predictive value for BMI, BAI, WHR, WHtR in identifying dyslipidemia. Analysis of simple and rapid parameters used to assess body fat, such as BMI, BAI, WHR, and WHtR, has shown that they are poor predictors of dyslipidemia in women with PCOS. In young women with PCOS, age appears to be a more reliable predictor of dyslipidemia.

Clinical and laboratory features of metabolic syndrome in young indigenous and non-indigenous residents of Western Siberia (on the example of the Khanty-Mansiysk Autonomous Okrug – Yugra)

Objective. To study the clinical and laboratory features of metabolic syndrome (MS) in young indigenous and non-indigenous residents of the Khanty-Mansi Autonomous Okrug – Yugra. Materials and methods. 863 young people aged 18–44 years were examined, of which 344 people had MS, 519 people without it. Comparison was made by ethnicity and gender. A general clinical examination, anthropometric study, measurement and assessment of blood pressure, lipid profile and fasting plasma glucose were conducted. Results. MS was detected in 42.9% of the total sample, in 40.7% of indigenous residents, and in 43.9% of non-indigenous residents. MS is common in 40.3% of men and 44.1% of women. MS was less common in indigenous men than in non-indigenous men (31.6% versus 43.5%). The incidence was identical in indigenous and non-indigenous women (44.1%). The prevalence of MS in indigenous men was 12.5% lower than in indigenous women (31.6% vs. 45.1%) (odds ratio 1.711; 95% confidence interval 0.980–2.986; p=0.058). The prevalence of MS in non-indigenous men (43.5%) and women (44.1%) was identical. Conclusion. A high prevalence of MS was established in young residents of the Khanty-Mansiysk Autonomous Okrug – Yugra. MS was more common in young women than in men. Indigenous women were 12.5% more likely to develop metabolic disorders than in indigenous men. The structure of MS in young people is characterized by frequent lipid profile disorders, in particular, hypertriglyceridemia. Abdominal obesity with dyslipidemia and hyperglycemia is common in non-native residents, and abdominal obesity with dyslipidemia and hypertension is common in the indigenous population.

Case Study on Management of Overweight (Sthoulya) through Ayurveda

ABSTRACT Modernization, affluence, and advancements in science and technology have led to increasingly sedentary lifestyles. This unintentionally invites a range of health issues, one of which is Sthoulya (overweight), which can affect physical, mental, and social health. Sthoulya refers to an individual who has excessive fat and flesh accumulation, causing a disproportional enlargement of the buttocks, belly, and breasts without a corresponding increase in energy. A 38-year-old female patient presented with weight gain, excessive hunger, sleep and sweating, lack of enthusiasm, and bad body odor. Before and after therapy, the patient was assessed for subjective and objective characteristics. There was an improvement in subjective parameters, anthropometric measurements, body mass index (BMI), and body weight after treatment. The combination therapy comprising Tryushanadi Guggul, Udvartan with Vacha Churna, and Peti Sweda demonstrated effectiveness in improving the lipid profile and anthropometric measurements of the patient over a 30-day treatment period.

Relation of albuminuria to some complications of chronic kidney disease in children: a single-center cross-sectional study

BackgroundChronic kidney disease is associated with several complications with higher prevalence and intensity at lower glomerular filtration rate. Albuminuria is the traditional biomarker of kidney damage. Although albuminuria can contribute to renal function decline, only a few studies have been published on whether albuminuria is associated with concurrent complications of chronic kidney disease. The aim of this work was to identify the relation between albuminuria and some of concurrent complications of chronic kidney disease among children.MethodsA cross-sectional study included fifty children with chronic kidney disease stages 2–5. Measurement of blood pressure, hemoglobin, serum bicarbonate, calcium, phosphorus, albumin, and lipid profile was done. Urinary albumin/creatinine ratio was determined. The relation between albuminuria and some of the complications of chronic kidney disease among children was studied.ResultsThe study included 50 patients aged 3–14 years. Dyslipidemia was present in 62% of the patients, acidosis in 56%, anemia in 38%, hyperphosphatemia in 34%, hypertension in 28%, and hypocalcemia in 22%. Eighty-eight percent had albuminuria, 26% had microalbuminuria, and 62% had macroalbuminuria. A statistically significant relation was found between the degree of albuminuria and presence of anemia and hyperphosphatemia. But no significant relation was found between the degree of albuminuria and presence of hypertension, dyslipidemia, acidosis, or hypocalcemia.ConclusionThere is a significant relation between the degree of albuminuria and presence of anemia and hyperphosphatemia among children with chronic kidney disease.

Spirulina Unleashed: A Pancreatic Symphony to Restore Glycemic Balance and Improve Hyperlipidemia and Antioxidant Properties by Transcriptional Modulation of Genes in a Rat Model.

Hyperlipidemia is the root cause of numerous chronic conditions, leading to high mortality rates around the globe. Spirulina (Arthrospira platensis) microalgae serve as a promising reservoir of bioactive compounds with diverse pharmacological properties. The current study examined the nutritional profile of spirulina powder in relation to strict glycemic control, specifically focusing on its potential to lower lipid levels. In an in vivo investigation, normal healthy male Wistar albino rats (n = 60) were divided into two groups: a negative control group (NC) of ten rats and a high-fat diet group (n = 50) that were fed a cholesterol-rich diet until their cholesterol levels reached or exceeded 250 mg/dL. Subsequently, the hypercholesterolemic rats were then randomly allocated to several treatment groups: a positive control (PC); a standard treatment diet (STD) involving fenofibrate at a dose of 20 mg/kg body weight; and three experimental groups (T1, T2, and T3) that received spirulina powder supplementation at doses of 300, 600, and 900 mg per kg body weight, respectively, for the period of 12 weeks. Blood samples were analyzed for oxidative stress biomarkers, insulin levels, lipid profiles, liver function, and expression of gene levels in the diabetogenic pathway. The study utilized spectrophotometric colorimetric methods to identify oxidative stress biomarkers, serum kit methods to measure lipid profiles and liver enzymes, and the assessment of qPCR for mRNA quantity. According to the research findings, spirulina powder has certain noteworthy features. It had the greatest quantity of chlorogenic acid (4052.90 µg/g) among seven phenolics and two flavonoid compounds obtained by HPLC-UV analysis. Furthermore, the proximate analysis demonstrated that spirulina is high in protein (16.45 ± 0.8%) and has a significant energy yield of 269.51 K-calories per 100 g. A maximal spirulina dose of 900 mg/kg/wt significantly lowered oxidative stress, cholesterol, triglyceride, low-density lipoproteins (LDL), and insulin levels (p ≤ 0.05). In contrast, high-density lipoprotein (HDL) and total antioxidant capacity (TAC) levels increased significantly (p ≤ 0.05) compared to all other groups, except the NC group. The study provides remarkable proof about the pharmacological impact of spirulina powders. Significant reductions (p ≤ 0.05) in liver enzymes {alanine aminotransferase (ALT) and aspartate aminotransferase (AST)} were observed across all treatment groups, with the exception of the NC, compared to the positive control. The treatment groups had significantly greater gene expression levels of INS-1, PDX-1, IGF-1, and GLUT-2 than the positive control group (p ≤ 0.05). These findings highlight spirulina's potential as a long-term regulator of hyperglycemia in rat models with induced hyperlipidemia, owing to its phenolic bioactive components that serve as antioxidants.

Preoperative Laparoscopic Sleeve Gastrectomy Improves Weight Loss Potential in Morbidly Obese Voluntary Kidney Donors

This was a retrospective study aimed at evaluating the efficacy of laparoscopic sleeve gastrectomy (LSG) as a strategy for weight loss in obese prospective voluntary kidney donors who were unable to achieve weight reduction through lifestyle changes. This retrospective study included living kidney donors who underwent LSG as a strategy for weight loss in obese prospective voluntary kidney donors between 2012 and 2022. Prospective donors who were initially rejected due to obesity underwent LSG after pretransplantation evaluation. Changes in weight, body mass index (BMI), and laboratory parameters (hemogram, kidney function tests, liver function tests, fasting and postprandial glycemia, HbA1c, and lipid profile measurements) were recorded before bariatric surgery and before nephrectomy. Of the 16 candidates who underwent LSG, one did not proceed with donor nephrectomy due to the intended recipient's death. Among the remaining 15 subjects, the average interval between bariatric surgery and donor nephrectomy was 165.95 ± 48.86 days. There was a significant decrease in BMI following bariatric surgery (P < .0001); the mean BMI before bariatric surgery was 40.94 ± 4.53 kg/m², and before nephrectomy, it was 30.91 ± 3.87 kg/m2. The mean weight loss was 22.64 ± 5.75 kg. This study supports LSG as an effective approach for obese individuals who are potential kidney donors to achieve weight loss, mitigate obesity-associated risks, and become successful kidney donors.

A digital health-supported and community pharmacy-based lifestyle intervention program for adults with pre-diabetes: a study protocol for a cluster randomised controlled trial

IntroductionPre-diabetes indicates an elevated risk of developing type-2 diabetes and presents a window for preventive actions. The Pre-diabetes Intervention, Management and Evaluation (PRIME) programme is a community pharmacy-based pre-diabetes management...

The Effect of Selenium, Zinc, and their Combined Supplementation on Cardiometabolic Biomarkers-comparing their Effects in the Energy Restriction and High-fat Diet Methods in Obese Rats.

The fat distribution in the body determines the risk of cardiometabolic problems such as heart disease and diabetes. Some dietary supplements, such as selenium and zinc, possess lipolytic and anti-angiogenic functions, which may be a useful strategy in reducing the risk of cardiometabolic complications. This study evaluated the effect of zinc (Zn), selenium (Se), and their combined supplementation on cardiometabolic risk factors in male Wistar rats in two nutritional models, including caloric restriction (CR) and high-fat diet (HFD). The 48 male Wistar rats were divided into three diet groups (HFD and CR and normal diet (ND)). The HFD group was subdivided into four groups (N=8 rats in each group) that received (HFD+Se), (HFD+Zn), (HFD+Zn+Se), and HFD alone as the control group, respectively. After 8 weeks of intervention, biochemical tests were performed on serum levels, including measurement of lipid profile (triglyceride, Cholesterol, LDL and HDL) and glycemic indices (fasting blood sugar, insulin and insulin sensitivity markers). The results showed that supplementation significantly improved the lipid profile (P <0.001). A comparison of glucose homeostasis indices in the study groups also showed a significant difference. The serum level of glucose was higher in the HFD group than in the intervention groups (P <0.001). Also, the rate of improvement of lipid profile and glycemic indexes in the group receiving the combination of two supplements showed a better trend than those receiving zinc and selenium alone. However, the values were statistically significant only for glucose homeostasis indices (P <0.001). Although obesity is a multifactorial condition, controlling other risk factors, zinc and selenium and their combined supplementation can lead to promising solutions for the treatment of obesity-induced glucose and lipid homeostasis disorders.

Ceramide As A Potential Tumor Marker For Diagnosis Of Prostate Cancer And Its Association With Lipid Profile

Background: Prostate cancer (PCa) is the second most frequent type of malignancy cancer among men worldwide. Ceramides are fatty acid derivatives of sphingoid bases, and formed not only through the de novo biosynthetic pathway, but also from the degradation of glycosphingolipids (GSLs) and ceramide-1-phosphate. Dyslipidaemia is part of metabolic syndrome, characterized by an alteration of the plasma lipid profile, including Cholesterol, HDL, and triglyceride levels. Objective Evaluate serum ceramide as tumer marker of prostate cancer and its association with lipid profile. Method This case- control study was carried out at Department of Biochemistry, College of Medicine, University of Baghdad and at Urology department, Ghazi Al-Hariri Hospital for surgical speciality during the period from March 2022 to May 2023. It included 120 men patients, 60 men patients who newly diagnosed to have primary prostate cancer (PCa), and 60 men were apparently healthy men. Investigations included serum measurements of ceramide by using enzyme linked immunosorbent assay(ELISA) and also measurement of lipid profile by using semi-auto biochemistry analyzer.Results The results of the present study showed that there was a significant differences in ceramide in prostate cancer patients as compared with the control group The results also showed that the S.Cholesterol, and S.Triglyceride were higher in the patients group compared to the controls group with significant statistical difference. Conclusion. According to the results obtained we can suggest that higher levels of ceramide, Cholesterol and Triglyceride may be associated with risk of prostate cancer.

P003 ASSOCIATION BETWEEN SERUM URIC ACID AND BLOOD PRESSURE IN BOYS, GIRLS AND ADOLESCENTS WITH OVERWEIGHT and OBESITY ATTENDED IN PEDIATRIC HOSPITALS IN THE AUTONOMOUS CITY OF BUENOS AIRES. “MULTICENTRIC STUDY

Introduction: Childhood overweight and obesity are modifiable risk factors for the development of Hypertension (HTN). Elevated serum uric acid (UA) is a known cardiovascular risk factor in adults. Objective: To evaluate whether there is an association between high serum UA values and elevated BP in overweight and obese children and adolescents. Methods: Multicenter prospective cross-sectional study. Overweight and obese patients aged 5 to 18 years attended in HTN outpatient clinics of three tertiary pediatric hospitals in Buenos Aires were included. Office BP control, 24-hours ambulatory BP monitoring (ABPM) and laboratory tests (metabolic and lipid profile and serum UA measurement) were performed. Results: 173 patients were enrolled, mean age 11.7±2.9 years, 63 women (36.4%), 50 were overweight (28.9%) and 123 obese (71.1%). 143 normotensive (NT) patients were registered, 14 with white-coat HTN, 11 with masked hypertension (MH) and 5 with sustained HTN. The mean value of serum UA was 5.1±1.2, 113 subjects were above the mean value and 24 were above 2SD. Taking serum UA higher than the average (n:113) according to BP we observed 89/143 in NT vs. 13/14 in white-coat HTN (OR 7.8 95% CI 1.1-62.1 p=0.04), 89/143 in NT vs. 8/11 in MH (OR 1.6 95% CI 0.4-6.3 p=0.7) and 89/143 in NT vs. 3/5 in sustained HTN (OR 0.9 95% CI 0.1-5.2 p=0.9). Using serum UA &gt;2SD (n:24) 14/143 above this value in NT vs. 7/14 in white-coat HTN (OR 9.2 95% CI 2.8-30.1 p&lt;0.001), 14/143 in NT vs. 3/11 MH (OR 3.4 95% CI 0.8-14.5 p=0.1) and no subject with sustained HTN had serum UA values &gt;2SD. Conclusions: Elevated serum UA was observed in subjects with white-coat HTN. The number of subjects with sustained HTN was not sufficient to evaluate the association with serum UA values. These findings emphasize the importance of the systematic implementation of 24-hours ABPM for detection of white-coat HTN in overweight and obese children and adolescents.

Lipid profile is significantly associated with sarcopenia status in elderly patients with metabolic syndrome

Background: Sarcopenia is a degenerative condition closely associated with the elderly, especially those with metabolic syndrome. Patients with sarcopenia often experience a decrease in muscle mass which is replaced by fat mass. Dyslipidemia through insulin resistance mechanisms can cause muscle dysfunction in the elderly. Additionally, low albumin levels can decrease muscle mass, worsening sarcopenia. Uric acid can also influence the development of sarcopenia. Sarcopenia sufferers tend to experience an increase in TNF-α levels due to insulin resistance. The incidence of metabolic syndrome with increased morbidity and mortality is more common among older individuals. The study aims to determine the relationship between lipid profile, albumin, TNF-α, and uric acid levels with sarcopenia status in elderly individuals with metabolic syndrome. Methods: An observational analytic study using a cross-sectional design. The subjects were 42 elderly individuals with metabolic syndrome. Plasma samples were used to measure lipid profile, albumin, TNF-α, and uric acid levels. Sarcopenia status was assessed through physical performance tests, hand grip strength, and BIA. Results: Total cholesterol, triglycerides, HDL, and LDL levels were significantly associated with sarcopenia status in elderly individuals with metabolic syndrome, while albumin, TNF-α, and uric acid levels were not. Conclusion: Lipid profile is significantly associated with sarcopenia status in elderly patients with metabolic syndrome.

A comparative study on lipid profile parameters in athlete and non-athlete adult males

Regular physical exercise has a major impact on lipid status. The particular characteristics of athletes' blood lipid profiles were examined in this literature study. When compared to a sex- and age-matched inactive group, professional athletes' blood lipid level was shown to be much better. Athletes perform lower levels of TC, LDL-C, and TG and equivalent or higher blood levels of HDL-C regardless of whether they participate in endurance or power sports. It was introduced that there are disparities in blood lipid levels and sports disciplines. Although there are many more elements that should be considered for future research, such as food, area of origin, exercise regimen, and even genetic susceptibility. To compare the lipid profile among athlete and no-athlete adult males. Case control study with sample size 150. Adult males of age group 20-50 &amp; apparently healthy males were taken. Serum lipid profile and various anthropometric measurements were done. Data Collection was done using a predesigned and pre-validated interview questionnaire. Serum cholesterol, Triglyceride, VLDL &amp; LDL values were raised in non-athletes compared to athletes and the difference was statistically significant. The serum HDL values were lower in non-athletes compared to the athletes and the difference was statistically significant (p&amp;#60;0.001). Our study concludes that athletes and non-athletes differ in their lipid profile status. Athletes have better lipid status as compared to non-athletes, thus well protected from the risk of cardiovascular diseases. Physical activity significantly promotes better lipid profile, irrespective of genetic influence.

Physiological and Histological Effects of Flaxseed Oil on the Liver and Heart Muscle

Abstract Background: Flaxseeds are the focus of medical nutrition due to their potential benefits for human health. Flaxseed oil is rich in unsaturated fatty acids and has many biological effects. Objective: This study aimed to assess the effects of flaxseed oil on lipid profile, liver, and heart. Materials and Methods: One hundred mice were randomly divided into 10 groups: 10 mice for each group (either male or female). Ten males and 10 females served as control groups, group 1 received flaxseed oil orally (60 mg/kg body weight/day). Twenty of them (10 of each gender) were treated for 1 week and another 20 mice (10 of each gender) were treated for 2 weeks. In the same way, group 2 was divided and treated with 120 mg/kg/day. Measurements of serum lipid profile, serum lactate dehydrogenase, serum total protein, and albumin were performed along with histological examination of the liver and heart. Results: The comparative data showed that there were statistically significant decreases in total cholesterol, low-density lipoprotein (LDL), serum albumin, and total protein levels. There were also statistically significant increases in levels of very low-density lipoprotein (VLDL), triglycerides, high-density lipoprotein (HDL), and lactate dehydrogenase enzyme. Histological examination revealed striking histological changes in the liver and heart. Conclusion: Consumption of flaxseed oil reduced total cholesterol and LDL levels and increased the levels of VLDL, triglycerides, HDL, and lactate dehydrogenase enzyme. Flaxseed oil in high doses causes damage to the liver and heart muscle.

Non-invasive laser therapy effect on lipid profile and renal function in metabolic syndrome: randomized control trial

INTRODUCTION. Metabolic syndrome (MetS) represents an assortment of interconnected metabolic risk factors, particularly central obesity, dyslipidemia, and hyperglycemia. These variables have a detrimental impact on renal function and contribute to increased mortality. This timeline necessitates a prompt approach that enables the deployment of safe and non-intrusive therapeutic equipment in conjunction with therapy for MetS patients. Accordingly, we aim to investigate whether using a low-level laser (LLL) watch device as a non-invasive instrument enhances multiple metabolic parameters, so it may be a practical therapeutic approach for managing metabolic disorders. AIM. To investigate the effect of non-invasive laser therapy on parameters of lipid profile and renal function in patients with metabolic syndrome. MATERIALS AND METHODS. This study enrolled 40 MetS patients of both genders aged 45–65 years. The study group received a 12-week treatment consisting of oral hypoglycemic medication and LLL therapy (LLLT), which involved three weekly sessions performed in the morning, targeting the wrist area using a continual output diode laser (skin contact mode, maximum power: 0.005 W, beam spot area: 0.03 cm2, energy density: 288 J/cm3, and radiation time: 1800 s). The control group only received hypoglycemia medications. Laboratory lipid profile and renal function measurements were conducted prior to and following the trial. RESULTS. Following a 12-week laser watch therapy, the results revealed a significant decline in total cholesterol (TC), triglycerides (TG), and low-density lipoprotein (LDL) levels and an increase in high-density lipoprotein (HDL) levels, which was slightly improved in the control (p 0.00). Moreover, glomerular filtration rate (GFR) and creatinine levels were significantly improved, while the control group did not experience any significant improvement (p 0.5). DISCUSSION. Combining non-invasive laser therapy with hypoglycemic medications significantly improved the lipid profile in patients with MetS; however, kidney function, like GFR and creatinine levels, was enhanced. Furthermore, lower TC and TG levels might be due to the reduction of glycation and promoted LDL receptors which increased LDL catabolism. CONCLUSION. Non-invasive laser therapy enhances lipid profile and renal function in MetS patients. Furthermore, the control group had a minimal effect on the lipid profile and no effect on renal function.